MOR106

Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
MorphoSys
Galapagos
Novartis
MOR106
atopic dermatitis
Dupixent
Sanofi
Novartis to Pay as Much as $1 Billion for Rights to Skin Drug
Yahoo/Bloomberg
Thu, 07/19/18 - 09:53 am
Novartis
Galapagos
MorphoSys
MOR106
atopic dermatitis